CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Biotech
Original article

Enact Receives Ratings Upgrade from AM Best

Positive
AI Analysis

Summary

Enact received a ratings upgrade from AM Best, reflecting strong performance and robust capital position. This is a routine credit rating update with no direct biotech/pharmaceutical clinical or regulatory implications.

Outcome Details

Ratings upgrade from AM Best

Importance:2/10
Sentiment:
0.60
ratings upgradecredit ratingcapital position

Read the original article

Published by GlobeNewswire Biotech on September 18, 2026 8:15 PM

Read Original